Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: Relationships with antibiotic use and cost drivers

Annals of Pharmacotherapy

Volumn 42, Issue 3, 2008, Pages 317-326

  Mauldin, Patrick D ^a,b   Salgado, Cassandra D ^a   Durkalski, Valerie L ^a   Bosso, John A ^a,c,d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Antibiotic use; Cost; Methicillin resistant Staphylococcus aureus; Vancomycin resistant Enterococcus

Indexed keywords

ANTIBIOTIC AGENT; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN; LINEZOLID; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG USE; ENTEROCOCCAL INFECTION; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HEALTH CARE COSTS; HUMANS; METHICILLIN RESISTANCE; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

EID: 41149125498     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1K501     Document Type: Article

References (17)

1. Rello J, Torres A, Ricart M, et al. Ventilator-associated pneumoniae by Staphylococcus aureus: comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994;150:1545-9.
2. Carbon C. Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci. J Antimicrob Chemother 1999;44(suppl A):31-6.
3. Abramson MA, Sexton DJ. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999;20:408-11.
4. Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003;36:592-8.
5. Linden PK, Pasculle AW, Manez R, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-sensitive Enterococcus faecium. Clin Infect Dis 1996;22:663-70.
6. Mainous MR, Lipsett PA, O'Brien M. Enterococcal bacteremia in the surgical intensive care unit. Arch Surg 1997;132:76-81.
7. Webb M, Riley LW, Roberts RB. Cost of hospitalization for and risk factors associated with vancomycin-resistant Enterococcus faecium infection and colonization. Clin Infect Dis 2001;33:445-52.
8. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003;36:131-9.
9. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003;24:362-86.
10. Centers for Disease Control/Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings, 2006. www.cdc.gov (accessed 2007 Mar 27).
11. Lowry FD. Staphylococcus aureus infections. N Eng J Med 1998;339:520-32.
12. Boyce JM, Opal SM, Chow JW, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994;32:1148-53.
13. Gillings D, Makuc D, Siegel E. Analysis of interrupted time series mortality trends: an example to evaluate regionalized perinatal care. Am J Public Health 1981;71:38-46.
14. Bosso JA, Mauldin PD. Assessment of effects of fluoroquinolone formulary changes on gram-negative susceptibility and MRSA isolation rates using interrupted time series analysis. Antimicrob Agents Chemother 2006;50:2106-12.
15. Mauldin PD, Weintraub WS, Becker ER. Predicting hospital costs for first-time coronary artery bypass grafting from pre-operative and postoperative variables. Am J Cardiol 1994;74:772-5.
16. Panlilio AL, Culver DH, Gaynes RP, et al. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol 1992;13:582-6.
17. Murdoch DR, Mirrett S, Harrell LJ, Monahan JS, Reller LB. Sequential emergence of antibiotic resistance in enterococcal bloodstream isolates over 25 years. Antimicrob Agents Chemother 2002;46:3676-8.